查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1879345

青蒿酸市場－全球產業規模、佔有率、趨勢、機會和預測，按類型（全合成、半合成）、應用（抗瘧注射、抗瘧錠）、地區和競爭格局分類，2020-2030年預測

Artemisinic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Total Synthesis, Semi synthesis), By Applications (Antimalarial Injections, Antimalarial Tablets), By Region, By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球青蒿酸市場規模為5.219億美元，預計2030年將以4.11%的複合年成長率成長至6.6457億美元。青蒿酸是一種重要的倍半萜類化合物，主要來自青蒿（Artemisia annua L.），是半合成青蒿素的關鍵前體，而青蒿素是抗瘧藥物中必不可少的活性藥物成分。市場擴張主要得益於幾個關鍵促進因素，包括全球持續存在的瘧疾負擔，這維持了對基於青蒿素的聯合療法的需求；以及微生物發酵等生物技術生產方法的不斷進步，這些進步提高了供應鏈的可靠性和成本可預測性。此外，對瘧疾以外其他治療應用的研究和開發投入不斷增加，也促進了市場成長。

市場概覽
預測期 2026-2030
2024年市場規模 5.219億美元
2030年市場規模 6.6457億美元
2025-2030年複合年成長率 4.11%
成長最快的細分市場 抗瘧疾藥片
最大的市場 中東和非洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球青蒿酸市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（全合成、半合成）
    • 依應用方式（抗瘧疾注射、抗瘧疾錠劑）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美青蒿酸市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲青蒿酸市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區青蒿酸市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲青蒿酸市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲青蒿酸市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球青蒿酸市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Sanofi SA
  • KPC Pharmaceuticals, Inc
  • Guilin Pharmaceutical Co., Ltd
  • Calyx Chemicals and Pharmaceuticals Ltd.
  • Novartis AG
  • Ipca Laboratories Ltd.
  • Cipla Inc.
  • Shin Poong Pharm Co., Ltd.
  • Rupus Global Limited
  • AdvacarePharma

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16108

The Global Artemisinic Acid Market, valued at USD 521.9 Million in 2024, is projected to experience a CAGR of 4.11% to reach USD 664.57 Million by 2030. Artemisinic acid, a pivotal sesquiterpene derived primarily from *Artemisia annua L. *, functions as a critical precursor for the semi-synthesis of artemisinin, an active pharmaceutical ingredient essential in antimalarial drugs. The market's expansion is robustly supported by several key drivers, including the persistent global burden of malaria, which sustains the demand for artemisinin-based combination therapies, and continuous advancements in biotechnological production methods like microbial fermentation, offering enhanced supply chain reliability and cost predictability. Furthermore, increasing investments in research and development exploring diverse therapeutic applications beyond malaria also contribute to market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 521.9 Million
Market Size 2030USD 664.57 Million
CAGR 2025-20304.11%
Fastest Growing SegmentAntimalarial Tablets
Largest MarketMiddle East & Africa

Key Market Drivers

The global artemisinic acid market is significantly influenced by the persistent burden of malaria worldwide and continuous advancements in biotechnological production methods. The enduring health crisis of malaria consistently drives demand for artemisinin-based combination therapies, which in turn elevates the need for artemisinic acid as a crucial precursor. The crisis necessitates a steady supply of effective antimalarial drugs. According to the World Health Organization (WHO), in December 2024, the Malaria Report stated that global malaria cases reached an estimated 263 million in 2023, underscoring the vast and ongoing need for treatment. Simultaneously, advancements in biotechnological production methods significantly enhance supply chain reliability and cost predictability for artemisinic acid. Synthetic biology innovations, particularly engineered microbial fermentation, revolutionize manufacturing.

Key Market Challenges

The emergence of artemisinin resistance in malaria parasites poses a significant challenge to the Global Artemisinic Acid Market. This resistance directly undermines the efficacy of artemisinin-based combination therapies, which are currently pivotal for malaria treatment. As parasites develop resistance, the sustained effectiveness of these essential drugs is jeopardized, leading to reduced confidence in artemisinin as a reliable active pharmaceutical ingredient. This instability threatens the consistent demand for artemisinic acid, its key precursor.

Developing new antimalarial drugs to overcome this resistance represents a substantial financial burden on the pharmaceutical industry. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the estimated cost for researching and developing a new chemical or biological entity was €3,130 million (equivalent to $3,296 million in 2022 dollars) in 2022. This considerable investment, required for ongoing innovation to counteract resistance, diverts resources and increases development timelines, thereby impeding stable market growth for established precursors like artemisinic acid.

Key Market Trends

The prioritization of sustainable production processes is emerging as a critical trend within the global artemisinic acid market. This focus extends beyond mere compliance, reflecting a concerted effort across the pharmaceutical industry to minimize environmental impact and promote ethical manufacturing practices throughout the supply chain. Companies are increasingly investing in green chemistry principles, adopting renewable energy sources, and implementing waste reduction strategies to enhance their ecological footprint. According to Cytiva's 2024 Global Biopharma Sustainability Review, sustainability ranks as the number one priority for 62% of biopharma companies over the next five years, indicating a significant shift towards environmentally conscious operations. This commitment drives innovation in manufacturing techniques, promoting resource efficiency and a reduced reliance on hazardous materials in the production of key pharmaceutical precursors like artemisinic acid.

Key Market Players

  • Sanofi SA
  • KPC Pharmaceuticals, Inc
  • Guilin Pharmaceutical Co., Ltd
  • Calyx Chemicals and Pharmaceuticals Ltd.
  • Novartis AG
  • Ipca Laboratories Ltd.
  • Cipla Inc.
  • Shin Poong Pharm Co., Ltd.
  • Rupus Global Limited
  • AdvacarePharma

Report Scope:

In this report, the Global Artemisinic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artemisinic Acid Market, By Type:

  • Total Synthesis
  • Semi synthesis

Artemisinic Acid Market, By Applications:

  • Antimalarial Injections
  • Antimalarial Tablets

Artemisinic Acid Market, By Region:

  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • North America
    • United States
    • Canada
    • Mexico

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Artemisinic Acid Market.

Available Customizations:

Global Artemisinic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artemisinic Acid Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Total Synthesis, Semi synthesis)
    • 5.2.2. By Applications (Antimalarial Injections, Antimalarial Tablets)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Artemisinic Acid Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Applications
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artemisinic Acid Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Applications
    • 6.3.2. Canada Artemisinic Acid Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Applications
    • 6.3.3. Mexico Artemisinic Acid Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Applications

7. Europe Artemisinic Acid Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Applications
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artemisinic Acid Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Applications
    • 7.3.2. France Artemisinic Acid Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Applications
    • 7.3.3. United Kingdom Artemisinic Acid Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Applications
    • 7.3.4. Italy Artemisinic Acid Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Applications
    • 7.3.5. Spain Artemisinic Acid Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Applications

8. Asia Pacific Artemisinic Acid Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Applications
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Artemisinic Acid Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Applications
    • 8.3.2. India Artemisinic Acid Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Applications
    • 8.3.3. Japan Artemisinic Acid Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Applications
    • 8.3.4. South Korea Artemisinic Acid Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Applications
    • 8.3.5. Australia Artemisinic Acid Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Applications

9. Middle East & Africa Artemisinic Acid Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Applications
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Artemisinic Acid Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Applications
    • 9.3.2. UAE Artemisinic Acid Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Applications
    • 9.3.3. South Africa Artemisinic Acid Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Applications

10. South America Artemisinic Acid Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Applications
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Artemisinic Acid Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Applications
    • 10.3.2. Colombia Artemisinic Acid Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Applications
    • 10.3.3. Argentina Artemisinic Acid Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Applications

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Artemisinic Acid Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Sanofi SA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. KPC Pharmaceuticals, Inc
  • 15.3. Guilin Pharmaceutical Co., Ltd
  • 15.4. Calyx Chemicals and Pharmaceuticals Ltd.
  • 15.5. Novartis AG
  • 15.6. Ipca Laboratories Ltd.
  • 15.7. Cipla Inc.
  • 15.8. Shin Poong Pharm Co., Ltd.
  • 15.9. Rupus Global Limited
  • 15.10. AdvacarePharma

16. Strategic Recommendations

17. About Us & Disclaimer